888-969-2592
Kalkine 0
countryflagCA

Alignment Healthcare LLC

Healthcare US ALHC

15.24USD
-0.18(1.17%)

Last update at 2025-05-09T16:44:00Z

Day Range

15.2415.70
LowHigh

52 Week Range

4.469.20
LowHigh

Fundamentals

  • Previous Close 15.42
  • Market Cap1368.98M
  • Volume389792
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-111.49900M
  • Revenue TTM2013.08M
  • Revenue Per Share TTM10.73
  • Gross Profit TTM 184.28M
  • Diluted EPS TTM-0.84

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -149.30000M -195.28600M -22.92600M -44.73200M
Minority interest 0.09M - - -
Net income -149.63900M -212.95800M -39.12500M -59.27800M
Selling general administrative 295.65M 290.99M 156.40M 110.13M
Selling and marketing expenses - - - -
Gross profit 184.28M 128.73M 166.23M 95.57M
Reconciled depreciation 17.49M 16.03M 15.46M 16.58M
Ebit -128.63900M -178.07200M -5.99500M -29.48400M
Ebitda -111.32900M -161.81000M 9.47M -13.25200M
Depreciation and amortization 17.31M 16.26M 15.46M 16.23M
Non operating income net other - -17.21400M - -
Operating income -128.63900M -178.07200M -5.99500M -29.48400M
Other operating expenses 1562.80M 1345.85M 964.49M 786.45M
Interest expense 18.29M 17.44M 16.93M 14.90M
Tax provision 0.34M 0.00000M - 0.00000M
Interest income - - - -
Net interest income -18.28900M -17.44300M -16.93100M -14.89700M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.34M 17.67M 16.20M 14.55M
Total revenue 1434.16M 1167.77M 959.22M 756.96M
Total operating expenses 312.92M 306.80M 171.49M 125.06M
Cost of revenue 1249.88M 1039.04M 792.99M 661.39M
Total other income expense net -20.66100M -17.21400M -16.93100M -15.24800M
Discontinued operations - - - -
Net income from continuing ops -149.63900M -195.28600M -22.92600M -44.73200M
Net income applicable to common shares -149.54700M -195.28600M -22.92600M -44.73200M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 591.88M 633.86M 630.89M 338.50M 193.44M
Intangible assets 5.25M 5.48M 5.81M 5.34M 5.67M
Earning assets - - - - -
Other current assets 44.97M 42.11M 27.75M 17.23M 5.24M
Total liab 433.81M 394.56M 324.84M 307.89M 272.15M
Total stockholder equity 156.95M 238.13M 306.04M 30.61M -78.71100M
Deferred long term liab - - - - -
Other current liab 92.95M 197.67M 149.81M 25.17M 12.52M
Common stock 0.19M 0.19M 0.19M 0.16M -
Capital stock 0.19M 0.19M 0.19M - -
Retained earnings -880.25800M -732.24100M -574.85600M 30.61M -78.71100M
Other liab - - - - 3.94M
Good will 34.83M 34.81M 29.30M 29.30M 29.30M
Other assets - 6.04M 4.71M 2.15M 3.68M
Cash 202.90M 409.55M 466.60M 207.31M 86.48M
Cash and equivalents - - - - -
Total current liabilities 263.02M 229.96M 167.25M 153.45M 130.26M
Current deferred revenue -1.71700M - - - -
Net debt -32.11700M -244.94900M -309.00500M -52.87200M 51.47M
Short term debt 1.72M - - - -
Short long term debt - - - - -
Short long term debt total 170.79M 164.60M 157.59M 154.44M 137.96M
Other stockholder equity 1037.02M 970.18M 880.71M 72.71M 57.73M
Property plant equipment - 42.99M 30.36M 37.03M 27.44M
Total current assets 483.54M 544.55M 552.86M 264.68M 127.35M
Long term investments - - - - -
Net tangible assets - 197.84M 270.92M -4.03400M -113.68200M
Short term investments 115.91M - - - -
Net receivables 119.75M 92.89M 58.51M 40.14M 35.63M
Long term debt 161.81M 160.90M 150.62M 144.17M 137.96M
Inventory - - - - -
Accounts payable 170.07M 32.29M 17.43M 128.28M 117.73M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - 0.01M - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -72.70700M -57.73000M
Additional paid in capital - - - - -
Common stock total equity - - 0.19M - -
Preferred stock total equity - - - - -
Retained earnings total equity - - -574.85600M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.41M 6.04M 4.71M 2.15M 3.68M
Deferred long term asset charges - - - - -
Non current assets total 108.34M 89.32M 78.04M 73.83M 66.09M
Capital lease obligations 8.97M 3.70M 6.97M 10.27M 0.00000M
Long term debt total - - 150.62M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -28.21700M -1.05000M -0.75000M 0.00500M
Change to liabilities 13.74M -0.80700M 0.65M 1.29M
Total cashflows from investing activities -28.21700M -20.81500M -16.35800M -10.24000M
Net borrowings 21.82M 21.82M 21.82M 55.00M
Total cash from financing activities 16.59M 360.13M 130.12M 52.66M
Change to operating activities 15.08M -2.24500M 7.24M 33.48M
Net income -149.63900M -195.28600M -22.92600M -44.73200M
Change in cash -57.05100M 260.54M 121.33M 51.63M
Begin period cash flow 468.35M 207.81M 86.48M 34.85M
End period cash flow 411.30M 468.35M 207.81M 86.48M
Total cash from operating activities -45.42700M -78.77600M 7.56M 9.21M
Issuance of capital stock 0.00000M 390.60M 135.00M 0.50M
Depreciation 17.49M 16.03M 15.46M 16.58M
Other cashflows from investing activities - -19.76500M - -
Dividends paid - - - -
Change to inventory - -13.51300M -11.87500M -2.88900M
Change to account receivables -34.37700M -17.60800M -4.62700M -5.78400M
Sale purchase of stock 0.00000M -1.47400M - -1.98100M
Other cashflows from financing activities 159.77M -28.99600M -4.87600M 54.15M
Change to netincome 90.34M 4.31M 9.58M 6.41M
Capital expenditures 23.77M 18.36M 15.71M 10.24M
Change receivables - -17.60800M - -
Cash flows other operating - 112.33M - -
Exchange rate changes - - - -
Cash and cash equivalents changes - 260.54M - -
Change in working capital 8.57M -19.41600M 3.25M 29.00M
Stock based compensation 81.72M 110.60M 2.12M 1.16M
Other non cash items -3.56100M 9.18M 8.52M 5.36M
Free cash flow -69.20100M -97.13600M -8.14700M -1.03700M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALHC
Alignment Healthcare LLC		 -0.18 1.17% 15.24 - - 0.49 5.66 0.41 -7.0294
UNH
UnitedHealth Group Incorporated		 -6.585 1.71% 378.96 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 -9.11 2.21% 403.27 18.00 12.66 0.65 2.87 0.74
CVS
CVS Health Corp		 -0.74 1.09% 67.11 12.06 9.08 0.29 1.34 0.47 8.96
CI
Cigna Corp		 -0.05 0.01% 333.06 30.25 10.09 0.39 2.10 0.50

Reports Covered

Stock Research & News

View All

Profile

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Alignment Healthcare LLC

1100 West Town and Country Road, Orange, CA, United States, 92868

Key Executives

Name Title Year Born
Mr. John E. Kao Pres, CEO & Director 1962
Mr. Robert Thomas Freeman Chief Financial Officer 1990
Dr. Dinesh M. Kumar M.D. Chief Medical & Operating Officer 1969
Ms. Dawn Christine Maroney Pres of Markets and CEO of Health Plan 1968
Ms. Charlotte LeBlanc Chief Accounting Officer and Sr. VP NA
Mr. Hakan Kardes Chief Technology Officer NA
Mr. Rob Scavo Chief Information Officer NA
Mr. Richard A. Cross Sr. VP & Gen. Counsel NA
Ms. Amanda Root VP of Corp. Communications NA
Ms. Supriya Sood Chief People Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.